Your browser doesn't support javascript.
loading
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.
Cortellini, Alessio; Buti, Sebastiano; Bersanelli, Melissa; Giusti, Raffaele; Perrone, Fabiana; Di Marino, Pietro; Tinari, Nicola; De Tursi, Michele; Grassadonia, Antonino; Cannita, Katia; Tessitore, Alessandra; Zoratto, Federica; Veltri, Enzo; Malorgio, Francesco; Russano, Marco; Anesi, Cecilia; Zeppola, Tea; Filetti, Marco; Marchetti, Paolo; Botticelli, Andrea; Cappellini, Gian Carlo Antonini; De Galitiis, Federica; Vitale, Maria Giuseppa; Rastelli, Francesca; Pergolesi, Federica; Berardi, Rossana; Rinaldi, Silvia; Tudini, Marianna; Silva, Rosa Rita; Pireddu, Annagrazia; Atzori, Francesco; Iacono, Daniela; Migliorino, Maria Rita; Gelibter, Alain; Occhipinti, Mario Alberto; Martella, Francesco; Inno, Alessandro; Gori, Stefania; Bracarda, Sergio; Zannori, Cristina; Mosillo, Claudia; Parisi, Alessandro; Porzio, Giampiero; Mallardo, Domenico; Fargnoli, Maria Concetta; Tiseo, Marcello; Santini, Daniele; Ascierto, Paolo A; Ficorella, Corrado.
Affiliation
  • Cortellini A; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
  • Buti S; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Bersanelli M; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Giusti R; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Perrone F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Di Marino P; U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.
  • Tinari N; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • De Tursi M; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
  • Grassadonia A; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Cannita K; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Tessitore A; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Zoratto F; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
  • Veltri E; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Malorgio F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Russano M; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Anesi C; Medical Oncology, "Santo Spirito" Hospital, Pescara, Italy.
  • Zeppola T; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Filetti M; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Marchetti P; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Botticelli A; U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.
  • Cappellini GCA; U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy.
  • De Galitiis F; Medical Oncology, Sapienza University of Rome, Rome, Italy.
  • Vitale MG; Medical Oncology (B), Policlinico Umberto I, Rome, Italy.
  • Rastelli F; Medical Oncology, IDI-IRCCS, Roma, Italy.
  • Pergolesi F; Medical Oncology, Sapienza University of Rome, Rome, Italy.
  • Berardi R; Medical Oncology, IDI-IRCCS, Roma, Italy.
  • Rinaldi S; Medical Oncology, IDI-IRCCS, Roma, Italy.
  • Tudini M; Medical Oncology, University Hospital of Modena, Modena, Italy.
  • Silva RR; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy.
  • Pireddu A; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy.
  • Atzori F; Oncology Clinic, Università Politecnica delle Marche, Ancona, Italy.
  • Iacono D; Oncology Clinic, Università Politecnica delle Marche, Ancona, Italy.
  • Migliorino MR; Medical Oncology, AV2 Fabriano ASUR Marche, Italy.
  • Gelibter A; Medical Oncology, AV2 Fabriano ASUR Marche, Italy.
  • Occhipinti MA; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy.
  • Martella F; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy.
  • Inno A; Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy.
  • Gori S; Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy.
  • Bracarda S; Medical Oncology (B), Policlinico Umberto I, Rome, Italy.
  • Zannori C; Medical Oncology (B), Policlinico Umberto I, Rome, Italy.
  • Mosillo C; Medical Oncology, "G. Mazzini" Hospital, Teramo, Italy.
  • Parisi A; Medical Oncology Unit, IRCCS, Sacro Cuore Don Calabria Hospital, Verona, Italy.
  • Porzio G; Medical Oncology Unit, IRCCS, Sacro Cuore Don Calabria Hospital, Verona, Italy.
  • Mallardo D; Medical Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
  • Fargnoli MC; Medical Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
  • Tiseo M; Medical Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
  • Santini D; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
  • Ascierto PA; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Ficorella C; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
Oncoimmunology ; 9(1): 1710389, 2020.
Article in En | MEDLINE | ID: mdl-32002308
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncoimmunology Year: 2020 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncoimmunology Year: 2020 Type: Article Affiliation country: Italy